title: Is there a demonstrated advantage to increase tamsulosin dosage in patients with benign prostatic hyperplasia?
authors: Department of Urology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
authors: Shachar
authors: S
authors: Aharony
authors: Department of Urology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
authors: Ornella
authors: O
authors: Lam
authors: Department of Urology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
authors: Jacques
authors: J
authors: Corcos
mesh_terms: D058668:Adrenergic alpha-1 Receptor Antagonists / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D017410:Practice Guidelines as Topic; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D013449:Sulfonamides / Q000008:administration & dosage*; D000077409:Tamsulosin
chemical_list: D058668:Adrenergic alpha-1 Receptor Antagonists; D013449:Sulfonamides; D000077409:Tamsulosin